Passa al contenuto
Merck

Frontotemporal lobar degeneration with MAPT mutation in an Italian-Polish family. A case report.

Folia neuropathologica (2015-01-13)
Teresa Wierzba-Bobrowicz, Eliza Lewandowska, Jacek Zaremba, Mariusz Berdyński, Cezary Żekanowski, Tomasz Stępień, Paulina Felczak, Sylwia Tarka
ABSTRACT

Frontotemporal lobar degeneration (FTLD) with mutations in the MAPT (microtubule-associated protein tau) gene (FTLD with MAPT mutation) is a neurodegenerative disease with various clinical phenotypes. We present an Italian- Polish family with a IVS10+3G>A mutation in the MAPT gene, linked with haplotype H1s in a male proband (Fig. 2, II.2, H1s/H1b diplotype) and his sister (Fig. 2, II.1, the H1s/H1j diplotype). This report presents clinical, neuropathological and genetic testing of the proband and his affected sister, two members of an Italian-Polish family consisting of 25 family members. Their clinical history includes dementia as well as movement and cardiovascular disorders. Magnetic resonance imaging showed frontal and temporal cerebral atrophy. Neuropathological studies of the brain samples showed loss of neurons, gliosis, and the occurrence of neurofibrillary tangles, numerous neuropil threads, coiled bodies and abundant deposits of tau protein, including 3- and 4-repeated isoforms in neurons and glial cells. Only in the male proband brain, there were Pick body-like deposits in granule neurons of the hippocampus. Pathology of vascular walls was found in both cases. Ultrastructurally, the male proband showed clusters of collagen fibers mainly in a pericyte position. Beside the typical neurofibrillary pathology, aggregated gliofilaments and lipofuscin deposits in astroglia are described. Our report suggests that FTLD with IVS10+3G>A MAPT mutation causes damage mainly to the central nervous system and induces neuropathological changes, depending on the haplotypes of MAPT. In the clinical course of this disease, damage of the cardiovascular system may also be observed.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Formaldeide, Molecular Biology, 36.5-38% in H2O
Sigma-Aldrich
Formaldeide, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
SAFC
Formaldeide, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
Formaldeide, Molecular Biology, BioReagent, ≥36.0% in H2O (T)
Sigma-Aldrich
Ematossilina
Sigma-Aldrich
Formaldeide, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
Ematossilina, certified by the BSC
Supelco
Formaldeide, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Sigma-Aldrich
Formaldeide, tested according to Ph. Eur.
Sigma-Aldrich
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C